Back to Search Start Over

Immunohistochemical analysis of IDH2R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity

Authors :
Pareja, Fresia
da Silva, Edaise M.
Frosina, Denise
Geyer, Felipe C.
Lozada, John R.
Basili, Thais
Da Cruz Paula, Arnaud
Zhong, Elaine
Derakhshan, Fatemeh
D'Alfonso, Timothy
Wen, Hannah Y.
Giri, Dilip D.
Hayes, Malcolm M.
Krings, Gregor
Bhargava, Rohit
Palazzo, Juan P.
Rakha, Emad A.
Hoda, Syed A.
Sanders, Melinda E.
Collins, Laura C.
Schnitt, Stuart J.
Chen, Yunn-Yi
Weigelt, Britta
Jungbluth, Achim A.
Reis-Filho, Jorge S.
Brogi, Edi
Source :
Modern Pathology; June 2020, Vol. 33 Issue: 6 p1056-1064, 9p
Publication Year :
2020

Abstract

Tall cell carcinoma with reverse polarity is a rare subtype of breast carcinoma with solid and papillary growth and nuclear features reminiscent of those of the tall cell variant of papillary thyroid carcinoma. These tumors harbor recurrent IDH2R172 hotspot mutations or TET2mutations, co-occurring with mutations in PI3K pathway genes. Diagnosis of tall cell carcinomas with reverse polarity is challenging in view of their rarity and the range of differential diagnosis. We sought to determine the sensitivity and specificity of IDH2 R172 immunohistochemistry for the detection of IDH2R172 hotspot mutations in this entity. We evaluated 14 tall cell carcinomas with reverse polarity (ten excision and five core needle biopsy specimens), 13 intraductal papillomas, 16 solid papillary carcinomas, and 5 encapsulated papillary carcinomas by Sanger sequencing of the IDH2R172 hotspot locus and of exons 9 and 20 of PIK3CA, and by immunohistochemistry using monoclonal antibodies (11C8B1) to the IDH2R172S mutation. The 14 tall cell carcinomas with reverse polarity studied harbored IDH2R172 hotspot mutations, which co-occurred with PIK3CAhotspot mutations in 50% of cases. None of the other papillary neoplasms analyzed displayed IDH2R172 mutations, however PIK3CAhotspot mutations were detected in 54% of intraductal papillomas, 6% of solid papillary carcinomas, and 20% of encapsulated papillary carcinomas tested. Immunohistochemical analysis with anti-IDH2 R172S antibodies (11C8B1) detected IDH2 R172 mutated protein in 93% (14/15) of tall cell carcinomas with reverse polarity samples including excision (n= 9/10) and core needle biopsy specimens (n= 5), whereas the remaining papillary neoplasms (n= 34) were negative. Our findings demonstrate that immunohistochemical analysis of IDH2 R172 is highly sensitive and specific for the detection of IDH2R172 hotspot mutations, and likely suitable as a diagnostic tool in the evaluation of excision and core needle biopsy material of tall cell carcinomas with reverse polarity.

Details

Language :
English
ISSN :
08933952 and 15300285
Volume :
33
Issue :
6
Database :
Supplemental Index
Journal :
Modern Pathology
Publication Type :
Periodical
Accession number :
ejs62055652
Full Text :
https://doi.org/10.1038/s41379-019-0442-2